Cross-sectional study reveals PrEP awareness among individuals in opioid treatment, suggesting a need for education.
This study examined PrEP awareness among HIV-negative individuals in treatment for opioid use disorder (OUD; n = 179), and associations with demographic characteristics, sexual and injection behaviors, and treatment modalities. Overall, 48% of participants reported PrEP awareness. Bivariate logistic regression showed that, compared to others, individuals who were older, African American/Black, and in methadone treatment less frequently reported PrEP awareness ( p ≤.018), while those who reported sex with a person who injects drugs, inpatient/day treatment, and self-help group attendance more frequently reported PrEP awareness ( p ≤.041). Increased education and outreach to PrEP eligible individuals in methadone and other opioid treatment programs appears warranted.
No takes yet. Share an insight, caveat, or question.
Buttram et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: